Anergis' Series A - II Round

Anergis raised a round of funding on February 06, 2014.

Anergis is a clinical-stage biopharmaceutical company based in Switzerland. Anergis discovers and develops synthetic allergy vaccines with the aim to provide allergy patients and doctors with a signif…

Articles about Anergis' Series A - II Round: